Navigation Links
NCI renews Fox Chase/Penn Ovarian Cancer 'SPORE' grant for a third 5-year term
Date:9/4/2009

PHILADELPHIA (September 3, 2009) National Cancer Institute (NCI) has renewed a $11.5 million Specialized Program of Research Excellence (SPORE) grant in prevention, diagnosis and treatment of ovarian cancer, which supports multidisciplinary research at Fox Chase Cancer Center and the University of Pennsylvania. First approved in 1999, this marks the third five-year term for the Fox Chase-Penn Ovarian SPORE.

"The SPORE program has always been a bold experiment in team science, and we are proud to see the progress of the Fox Chase-Penn SPORE recognized through this grant renewal," says Michael Seiden, M.D., Ph.D., president and CEO of Fox Chase Cancer Center and principal investigator of the Ovarian Cancer SPORE. George Coukos, M.D., from Penn and Andrew K Godwin, Ph.D., of Fox Chase, serve as co-principal investigators on this SPORE.

According to Seiden and his colleagues, the Fox Chase-Penn SPORE has generated many positive ripple effects across both NCI-designated Cancer Centers. Since the inception of the program, both Penn and Fox Chase have invested an additional $13.4 million in support of gynecological oncology clinical and research infrastructure. The SPORE has also served as an important career development for young investigators and an incubator for new lines of scientific inquiry. In the last five years, alone, Fox Chase-Penn SPORE research has generated over $10 million in related grants.

"We have been able to leverage the expertise gained through SPORE research to recruit and foster the talents of many young investigators over the last decade," Seiden says. "This in turn has led to the adoption of new techniques and technologies that have advanced the science of ovarian cancer and will we have every reason to anticipate advance clinical care, as well."

The Fox Chase-Penn SPORE focuses on three central concepts in ovarian cancer. The first is epigenetics, the study of modifications made to the human genome that influence
'/>"/>

Contact: Greg Lester
gregory.lester@fccc.edu
215-728-2753
Fox Chase Cancer Center
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Wacoal Renews Successful Support the Girls Program
2. Coalition America Renews Relationship with Musketeer to Offer Streamlined Claims Repricing and Adjudication Solution for Benefit Administrators
3. NIH/NCI renews and extends nationwide license for Genomatix software and databases
4. Sanofi-Aventis renews licenses for Genomatix chip analysis pipeline
5. Independence Technology, A Johnson & Johnson Company, Renews Its Contract With Creative Technology Services
6. Acclamation Systems, Inc. Renews Partnership with Coalition America to Offer Streamlined Repricing and Adjudication Solution
7. FDA Renews Warnings on Pain-Relief Patch
8. Heart Association Renews Call for CPR Training
9. ABQAURP Renews Agreement with the National Board of Medical Examiners to Oversee Testing Methodology
10. FDA Renews its Contract with Beaumont Technology Usability Center for Leadership of Patient Safety Project
11. Governor Rendell Says 2008-09 Budget Renews Commitment to Vulnerable Pennsylvanians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... CA (PRWEB) March 02, 2015 Dr. ... personal injury, is partnering with Doctors on Liens ... more patients. It’s rare for personal injury victims ... office and especially on a lien basis. However, ... its outstanding team of chiropractors, M.D., pain management physician, ...
(Date:3/2/2015)... Cutler Integrative Medicine a leader in bringing innovative naturopathic ... to bring about self-renewal. A 30 day detox is ... cleaning house. According to Dr. Cutler, expert in ... environmental toxins like heavy metals, people’s food now becoming ... levels, we all have a level of toxic burden. ...
(Date:3/2/2015)... 02, 2015 Today the Brain Injury Association ... a time to recognize and support the more than 5.3 ... Each year BIAA leads the nation in observing Brain Injury ... of March. The theme for the 2015 to 2017 campaign ... a platform for educating the general public about the incidence ...
(Date:3/2/2015)... 2015 Surgeons at the Forbes ... Health Network, are exploring an innovative use of ... Info Zonal Reminder (VIZR), to assist in the care ... Glass is a wearable technology with an optical head-mounted ... Wearers communicate with the Internet via natural language voice ...
(Date:3/2/2015)... March 02, 2015 1% for the ... celebrate the addition of over 25 new business members at ... West in Anaheim, Calif. 1% for the Planet welcomes them ... will join through its nut butter line. , Food ... dispose of waste - continues to be a complex environmental ...
Breaking Medicine News(10 mins):Health News:Distinguished Doctor Brings His Multi-Specialty Medical Group to Doctors on Liens in San Diego 2Health News:Skin and Wellness Power Couple give Quick Tips to Self-Renewal for Spring 2Health News:Brain Injury Association of America Launches “Not Alone” Campaign for Brain Injury Awareness Month 2Health News:Pennsylvania Hospital Explores Use of Google Glass for Trauma Care 2Health News:Pennsylvania Hospital Explores Use of Google Glass for Trauma Care 3Health News:1% For the Planet Members Shine Light on Food as Environmental Issue at Expo West 2Health News:1% For the Planet Members Shine Light on Food as Environmental Issue at Expo West 3
... Associates, LLC,announced today that it has issued an ... (UNI-ASX). The full 72-page,report can be found at ... Unilife Medical Solutions Limited ... medical devices to healthcare and,pharmaceutical markets. Specifically, the ...
... 7 Perrigo Company (Nasdaq:, PRGO ; TASE) ... Papa will,present at the 27th Annual JPMorgan Healthcare Conference ... Westin St. Francis Hotel in San Francisco. , ... healthcare supplier that develops,manufactures and distributes OTC and prescription ...
... ability to eliminate disease by 2010 , , WEDNESDAY, Jan. ... elimination of measles in Europe by 2010, as ... countries where outbreaks have occurred in recent years. ... measles cases reported on the continent during the years ...
... TALLAHASSEE, Fla., Jan. 7 The Florida Department ... helping hand to the 28,000,Floridians who smoke to ... available,from the Florida Quitline (1-877-U-CAN-NOW) in the form ... patches, gum and lozenges. An ad,campaign blanketing the ...
... KING OF PRUSSIA, PA, Jan. 7 /PRNewswire-FirstCall/ - ... drug discovery and development solutions, today announced the ... Chief Financial Officer. , Mr. Howard has extensive ... pharmaceutical and contract research organization (CRO) industry sectors, ...
... Jan. 7 AGA Medical Corporation ("AGA,Medical") announced ... Ministry,of Health, Labour and Welfare (MHLW) for its ... transcatheter occlusion device used for the,non-surgical closure of ... heart defect that occurs when a blood vessel ...
Cached Medicine News:Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Unilife Medical Solutions Limited 2Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Unilife Medical Solutions Limited 3Health News:Europe Unlikely to Meet Measles Goals: Report 2Health News:State's 'Be Free' Anti-Tobacco Campaign Lends Smokers a Helping Hand 2Health News:MDS Pharma Services Names Rudy Howard Chief Financial Officer 2Health News:AGA Medical Receives Japanese Approval for AMPLATZER(R) Duct Occluder 2Health News:AGA Medical Receives Japanese Approval for AMPLATZER(R) Duct Occluder 3
(Date:3/2/2015)... -- When someone gets sick, their first course of ... physician or an urgent care facility to receive treatment. ... by doctors and medical professionals comes from facilities such ... in every circumstance. Though it may seem counter intuitive, ... higher chances of contracting illnesses. Also, simply traveling to ...
(Date:3/2/2015)... MIAMI , March 2, 2015  Vivex Biomedical, ... patterning technology, and biocellular products, announced today that it ... Operating Officer of UMTB Biomedical, Inc.   Vivex Biomedical formed ... University of Miami Tissue Bank (UMTB) in November 2014. ... Mr. Barnes is a twenty-five year veteran ...
(Date:3/2/2015)...   Oriel STAT A MATRIX announces ... most critical compliance and performance issues in the ... are experiencing an industry-transforming level of demand and ... global supply chains are negatively impacting product quality ... regulators are increasing compliance requirements, scrutiny, and enforcement. ...
Breaking Medicine Technology:House Call Medicine Helps Patients Receive Treatment While Avoiding the Hassles and Potential Risks of an Urgent Care Facility 2Vivex Biomedical, Inc. Announces New Chief Operating Officer of Tissue Bank 2Vivex Biomedical, Inc. Announces New Chief Operating Officer of Tissue Bank 3Oriel STAT A MATRIX Announces New Professional Certification Programs for Medical Device Regulatory and Quality Assurance Professionals 2Oriel STAT A MATRIX Announces New Professional Certification Programs for Medical Device Regulatory and Quality Assurance Professionals 3
... Calif., May 17 Essentialis Inc, a clinical ... its primary endpoint of statistically significant triglyceride reduction ... in dyslipidemic patients. The study encompassed both patients ... included normal weight, overweight and obese patients presenting ...
... analysis presented at 19th annual European Congress of Clinical ... , Finland SAN DIEGO, May 17 ... that the results from its North American Phase 3 ... difficile infection (CDI) were presented today by clinical ...
Cached Medicine Technology:Essentialis Meets Primary Endpoint in Phase 2b Trial of DCCR for Treatment of Hypertriglyceridemia and is Granted Extensive Patent Coverage in the US 2Essentialis Meets Primary Endpoint in Phase 2b Trial of DCCR for Treatment of Hypertriglyceridemia and is Granted Extensive Patent Coverage in the US 3Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection 2Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection 3Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection 4Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection 5
A portable, easy to use, dual-channel laser-Doppler tissue perfusion and temperature monitoring system, at a remarkably affordable price....
... high performance laser doppler system for ... blood perfusion. This latest generation single-channel ... with its multi-channel brother (Oxyflo), including ... and laser doppler flowmetry providing a ...
Transcranial vascular DWL doppler....
Transcranial vascular DWL doppler....
Medicine Products: